BAXNYSE

Baxter International Inc.

Healthcare·Oncology·Commercial·Deerfield, IL, United States
OncologyReproductive

Baxter International Inc. (BAX): 6 pipeline candidates · ~12 mo cash runway · 1 clinical trial. Updated within the last hour.

6.6/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway3.3

12.0 months

Financial Health3.1

D/E 2.29

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth9.8

6 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Baxter International Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$10.6B

Cash

$2.0B

Quarterly Burn

$867.0M

Runway

12.0 mo

Revenue

$2.7B

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jun 2027
Today~13 mo out
Catalyst within runway

Pipeline (6 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

661

Total value held

$9.15B

HolderSharesValue
blackrock, inc.79,400,664$1.33B
vanguard capital management llc67,013,950$1.13B
pzena investment management llc64,527,823$1.08B
dodge & cox57,254,570$961.9M
fmr llc46,264,804$777.2M
vanguard portfolio management llc23,993,355$403.1M
state street corp19,979,957$335.9M
greenhaven associates inc14,307,688$240.4M
geode capital management, llc13,762,965$230.8M
morgan stanley7,347,972$123.4M

Showing top 10 of 661 institutional holders of Baxter International Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

1 clinical trial·7 FDA decisions·CEO: Mr. Andrew P. Hider

Frequently asked questions

How many drug candidates are in Baxter International Inc.'s pipeline?

Baxter International Inc. (BAX) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Baxter International Inc.'s lead drug candidate?

Baxter International Inc.'s most advanced tracked candidate is adept adhesion reduction (Approved) for Obstetrics/Gynecology.

What is Baxter International Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Baxter International Inc. has approximately 12.0 months of cash runway.

What is Baxter International Inc.'s market capitalization?

Baxter International Inc.'s market capitalization is approximately $10.6B.

Who is the CEO of Baxter International Inc.?

Mr. Andrew P. Hider is the chief executive officer of Baxter International Inc. (BAX).

Get the full picture on Baxter International Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.